1. EachPod

Project Oncology® - Podcast

Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Health Science & Medicine Medicine
Update frequency
every 5 days
Episodes
347
Years Active
2015 - 2025
Share to:
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

Guest: Betsy O'Donnell, MD

Plasma cell disorders range from multiple myeloma to the monoclonal gammopathy of undetermined significance (MGUS), which is a benign condition that affects anywh…

Mon 16 Sep 2024
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

Guest: Betsy O'Donnell, MD

Plasma cell disorders range from multiple myeloma to the monoclonal gammopathy of undetermined significance (MGUS), which is a benign condition that affects anywh…

Mon 16 Sep 2024
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care

Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care

Host: Saad Z. Usmani, MD, MBA, FACP
Guest: Joshua Richter, MD
Guest: Ashley Steinberger, APP

Release date: 8/15/2024
Expiration date: 8/15/2025
Estimated time to complete: 1.0 hour

Th…

Thu 15 Aug 2024
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

Guest: David Braun

Identifying biomarkers for renal cell carcinoma (RCC) is critical since they can help direct our therapeutic approach, which is why several techniques that may be able to…

Tue 30 Jul 2024
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

Guest: David Braun

Identifying biomarkers for renal cell carcinoma (RCC) is critical since they can help direct our therapeutic approach, which is why several techniques that may be able to…

Tue 30 Jul 2024
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

Guest: David Braun, MD, PhD

A recent study investigated whether renal cell carcinoma (RCC) molecular subtypes have any impact on treatment outcomes. Here to share the surprising findings an…

Mon 29 Jul 2024
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

Guest: David Braun, MD, PhD

A recent study investigated whether renal cell carcinoma (RCC) molecular subtypes have any impact on treatment outcomes. Here to share the surprising findings an…

Mon 29 Jul 2024
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

Guest: Robert Wong, MD

Since the guidelines for diagnosing and treating hepatocellular carcinoma are often lengthy and complicated, it can be difficult for clinicians to stay up to date on …

Tue 23 Jul 2024
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

Guest: Robert Wong, MD

Since the guidelines for diagnosing and treating hepatocellular carcinoma are often lengthy and complicated, it can be difficult for clinicians to stay up to date on …

Tue 23 Jul 2024
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma

Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma

Host: Jesus G. Berdeja, MD
Guest: Nicholas G. Barkemeyer, MPAS
Guest: Ajai Chari, MD
Guest: Harvey Church
Guest: Amy Gebhardt
Guest: Steven Morrow

Release date: 7/18/202…

Thu 18 Jul 2024
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

Host: Matt Birnholz, MD
Guest: Saad Kenderian M.B, Ch.B

CAR T-cell therapy has been revolutionary in the treatment of blood cancers like chronic lymphocytic leukemia and multiple myelom…

Tue 16 Jul 2024
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

Host: Matt Birnholz, MD
Guest: Saad Kenderian M.B, Ch.B

CAR T-cell therapy has been revolutionary in the treatment of blood cancers like chronic lymphocytic leukemia and multiple myelom…

Tue 16 Jul 2024
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

Guest: Robert Wong, MD

Hepatitis B is one of the leading causes of liver cancer globally, underscoring the importance of screening, diagnosing, and treating patients appropriately. However,…

Tue 09 Jul 2024
Current Updates in Brain Imaging and Neurodegenerative Diseases

Current Updates in Brain Imaging and Neurodegenerative Diseases

Guest: Phillip H. Kuo, MD, PhD

One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently appro…

Tue 09 Jul 2024
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

Guest: Robert Wong, MD

Hepatitis B is one of the leading causes of liver cancer globally, underscoring the importance of screening, diagnosing, and treating patients appropriately. However,…

Tue 09 Jul 2024
Current Updates in Brain Imaging and Neurodegenerative Diseases

Current Updates in Brain Imaging and Neurodegenerative Diseases

Guest: Phillip H. Kuo, MD, PhD

One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently appro…

Tue 09 Jul 2024
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

Guest: Robert Wong, MD

A recent study explored clinician-level gaps and barriers to hepatocellular carcinoma surveillance in patients with cirrhosis and found that there is a lot of work to…

Wed 03 Jul 2024
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

Guest: Robert Wong, MD

A recent study explored clinician-level gaps and barriers to hepatocellular carcinoma surveillance in patients with cirrhosis and found that there is a lot of work to…

Wed 03 Jul 2024
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

Host: Jennifer Caudle, DO
Guest: Patricia A. Mangan, RN, MSN, APRN-BC

The expansion of treatment options and strategies across the disease continuum is good news for patients who previo…

Tue 02 Jul 2024
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

Guest: Geoffrey B. Johnson, M.D., Ph.D.

When looking at patients who suffer from prostate cancer who are receiving PSMA therapy, we can see on our images that the medication not only goes t…

Mon 01 Jul 2024
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.